Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

× No keyword cloud information.

108 in total

Review 1. Vasopeptidase inhibition: a new direction in cardiovascular treatment.

Authors: J R Asher; A J Naftilan
Journal: Curr Hypertens Rep Date: 2000-08 Impact factor: 5.369

2. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors: S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal: N Engl J Med Date: 2000-01-20 Impact factor: 91.245

3. Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart.

Authors: C Kositprapa; R A Ockaili; R C Kukreja
Journal: J Mol Cell Cardiol Date: 2001-07 Impact factor: 5.000

4. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin.

Authors: M ROCHA E SILVA; W T BERALDO; G ROSENFELD
Journal: Am J Physiol Date: 1949-02

5. Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides.

Authors: J Ozaki; H Shimizu; Y Hashimoto; H Itoh; K Nakao; K Inui
Journal: Eur J Pharmacol Date: 1999-04-16 Impact factor: 4.432

6. Protective effect of ACE inhibitors on ischemia-reperfusion-induced arrhythmias in rats: is this effect related to the free radical scavenging action of these drugs?

Authors: M Birincioglu; T Aksoy; E Olmez; A Acet
Journal: Free Radic Res Date: 1997-10

7. Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs.

Authors: G Takagi; K Kiuchi; T Endo; T Yamamoto; N Sato; J Nejima; T Takano
Journal: J Cardiovasc Pharmacol Date: 2000-07 Impact factor: 3.105

8. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.

Authors: G F Baxter; M S Marber; V C Patel; D M Yellon
Journal: Circulation Date: 1994-12 Impact factor: 29.690

9. Coronary endothelial dysfunction increases the severity of ischaemia-induced ventricular arrhythmias in rat isolated perfused hearts.

Authors: Z F Hassanabad; B L Furman; J R Parratt; E Aughey
Journal: Basic Res Cardiol Date: 1998-08 Impact factor: 17.165

10. Evidence that prostaglandins I2, E2, and D2 may activate ATP sensitive potassium channels in the isolated rat heart.

Authors: J F Bouchard; E Dumont; D Lamontagne
Journal: Cardiovasc Res Date: 1994-06 Impact factor: 10.787

23 in total

1. B Type natriuretic peptide: a good omen in myocardial ischaemia?

Authors: S P D'Souza; G F Baxter
Journal: Heart Date: 2003-07 Impact factor: 5.994

2. Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced Akt/eNOS phosphorylation and angiogenesis.

Authors: Zu-Long Sheng; Yu-Yu Yao; Ye-Fei Li; Cong Fu; Gen-Shan Ma
Journal: Am J Transl Res Date: 2015-06-15 Impact factor: 4.060

3. Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling.

Authors: W Keith Jones; Guo-Chang Fan; Siyun Liao; Jun-Ming Zhang; Yang Wang; Neal L Weintraub; Evangelia G Kranias; Jo El Schultz; John Lorenz; Xiaoping Ren
Journal: Circulation Date: 2009-09-15 Impact factor: 29.690

Review 4. Pharmacological attenuation of myocardial reperfusion injury in a closed-chest porcine model: a systematic review.

Authors: Sarah Ekeløf; Jacob Rosenberg; Jan Skov Jensen; Ismail Gögenur
Journal: J Cardiovasc Transl Res Date: 2014-07-09 Impact factor: 4.132

5. A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.

Authors: Francesca Bellucci; Stefania Meini; Paola Cucchi; Claudio Catalani; Wolfgang Reichert; Sabrina Zappitelli; Luigi Rotondaro; Laura Quartara; Alessandro Giolitti; Carlo Alberto Maggi
Journal: Br J Pharmacol Date: 2003-08-26 Impact factor: 8.739

6. Role of proteases in the pathophysiology of cardiac disease.

Authors: Raja B Singh; Sucheta P Dandekar; Vijayan Elimban; Suresh K Gupta; Naranjan S Dhalla
Journal: Mol Cell Biochem Date: 2004-08 Impact factor: 3.396

Review 7. Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling.

Authors: Emmanuel Eroume A Egom; Yunbo Ke; R John Solaro; Ming Lei
Journal: Prog Biophys Mol Biol Date: 2010-01-18 Impact factor: 3.667

8. Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase.

Authors: Yunbo Ke; Katherine A Sheehan; E Eroume A Egom; Ming Lei; R John Solaro
Journal: Am J Physiol Heart Circ Physiol Date: 2010-02-12 Impact factor: 4.733

Review 9. Nitric oxide homeostasis as a target for drug additives to cardioplegia.

Authors: B K Podesser; S Hallström
Journal: Br J Pharmacol Date: 2007-05-08 Impact factor: 8.739

10. Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced Akt/eNOS phosphorylation and angiogenesis.

Authors: Zu-Long Sheng; Yu-Yu Yao; Ye-Fei Li; Cong Fu; Gen-Shan Ma
Journal: Am J Transl Res Date: 2015-07-15 Impact factor: 4.060